Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Meeting Abstract
| Authors: | Messersmith, W.; Cohen, S.; Shahda, S.; Lenz, H. J.; Weekes, C.; Dotan, E.; Denlinger, C.; Kapoun, B. O. A.; Kapoun, A.; Zhang, C.; Henner, R.; Cattaruzza, F.; Xu, L.; Dupont, J.; Brachmann, R.; Uttamsingh, S.; Farooki, A.; Berlin, J. |
| Abstract Title: | Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi228 |
| Language: | English |
| ACCESSION: | WOS:000393912500683 |
| DOI: | 10.1093/annonc/mdw371.69 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 677P -- Source: Wos |
